Two Sigma Advisers LP reduced its position in Perrigo (NYSE:PRGO) by 29.2% in the 4th quarter, Holdings Channel reports. The firm owned 24,748 shares of the company’s stock after selling 10,222 shares during the quarter. Two Sigma Advisers LP’s holdings in Perrigo were worth $2,157,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Greenlight Capital Inc. raised its stake in Perrigo by 14.8% in the 3rd quarter. Greenlight Capital Inc. now owns 2,901,032 shares of the company’s stock valued at $245,572,000 after purchasing an additional 374,032 shares during the last quarter. Victory Capital Management Inc. raised its stake in Perrigo by 90.5% in the 4th quarter. Victory Capital Management Inc. now owns 2,046,980 shares of the company’s stock valued at $178,414,000 after purchasing an additional 972,210 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd raised its stake in Perrigo by 356.7% in the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 1,436,621 shares of the company’s stock valued at $125,216,000 after purchasing an additional 1,122,068 shares during the last quarter. Geode Capital Management LLC raised its stake in Perrigo by 1.8% in the 4th quarter. Geode Capital Management LLC now owns 1,404,828 shares of the company’s stock valued at $122,193,000 after purchasing an additional 24,521 shares during the last quarter. Finally, Virtus Fund Advisers LLC increased its stake in shares of Perrigo by 37.3% in the 4th quarter. Virtus Fund Advisers LLC now owns 952,550 shares of the company’s stock worth $83,024,000 after acquiring an additional 258,825 shares during the last quarter. 79.11% of the stock is owned by hedge funds and other institutional investors.
A number of analysts have issued reports on PRGO shares. Cantor Fitzgerald set a $107.00 target price on Perrigo and gave the stock a “buy” rating in a research note on Friday, January 12th. Canaccord Genuity set a $100.00 target price on Perrigo and gave the stock a “buy” rating in a research note on Monday, January 1st. Berenberg Bank started coverage on Perrigo in a research note on Thursday, February 1st. They issued a “buy” rating and a $117.00 target price for the company. Finally, JPMorgan Chase reaffirmed a “neutral” rating and issued a $83.00 target price (up from $82.00) on shares of Perrigo in a research note on Monday, March 5th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and nine have assigned a buy rating to the company’s stock. Perrigo presently has a consensus rating of “Hold” and a consensus price target of $91.88.
NYSE PRGO opened at $81.99 on Friday. The firm has a market cap of $11,790.59, a PE ratio of 16.63, a price-to-earnings-growth ratio of 2.08 and a beta of 0.76. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.96 and a quick ratio of 1.40. Perrigo has a twelve month low of $63.68 and a twelve month high of $95.93.
Perrigo (NYSE:PRGO) last released its quarterly earnings results on Thursday, March 1st. The company reported $1.28 earnings per share for the quarter, topping analysts’ consensus estimates of $1.25 by $0.03. The business had revenue of $1.28 billion during the quarter, compared to analysts’ expectations of $1.26 billion. Perrigo had a return on equity of 11.54% and a net margin of 2.42%. The company’s revenue was down 3.6% compared to the same quarter last year. During the same period in the prior year, the business posted $1.24 EPS. equities analysts expect that Perrigo will post 5.23 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 20th. Stockholders of record on Friday, March 2nd were issued a dividend of $0.19 per share. The ex-dividend date of this dividend was Thursday, March 1st. This is a boost from Perrigo’s previous quarterly dividend of $0.16. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.93%. Perrigo’s dividend payout ratio is currently 15.42%.
In other Perrigo news, CEO Uwe Roehrhoff purchased 7,500 shares of the stock in a transaction dated Monday, March 5th. The stock was acquired at an average cost of $81.85 per share, for a total transaction of $613,875.00. Following the acquisition, the chief executive officer now owns 4,900 shares in the company, valued at approximately $401,065. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 6.90% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This piece was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece on another website, it was illegally stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece can be accessed at https://www.dispatchtribunal.com/2018/04/08/two-sigma-advisers-lp-sells-10222-shares-of-perrigo-prgo.html.
Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.
Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo (NYSE:PRGO).
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.